Matches in Nanopublications for { ?s ?p "[This phase II study assesses the impact of second-line weekly irinotecan (CPT-11)/docetaxel in non-small cell lung cancer (NSCLC) patients, and gauges the uridine diphosphate glucuronosyl transferase (UGT1A1) polymorphism influence in toxicity and antitumor activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[This phase II study assesses the impact of second-line weekly irinotecan (CPT-11)/docetaxel in non-small cell lung cancer (NSCLC) patients, and gauges the uridine diphosphate glucuronosyl transferase (UGT1A1) polymorphism influence in toxicity and antitumor activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This phase II study assesses the impact of second-line weekly irinotecan (CPT-11)/docetaxel in non-small cell lung cancer (NSCLC) patients, and gauges the uridine diphosphate glucuronosyl transferase (UGT1A1) polymorphism influence in toxicity and antitumor activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP418726.RAASKb_L_LkoQWvAD5m9qJLnkZ-1WAZapf_UCInAY6ZeA130_assertion description "[This phase II study assesses the impact of second-line weekly irinotecan (CPT-11)/docetaxel in non-small cell lung cancer (NSCLC) patients, and gauges the uridine diphosphate glucuronosyl transferase (UGT1A1) polymorphism influence in toxicity and antitumor activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418726.RAASKb_L_LkoQWvAD5m9qJLnkZ-1WAZapf_UCInAY6ZeA130_provenance.
- NP925828.RADuFU5LtWwiwsnxXZniUP5TsVnxY8Jb3uvRLgqLby6-U130_assertion description "[This phase II study assesses the impact of second-line weekly irinotecan (CPT-11)/docetaxel in non-small cell lung cancer (NSCLC) patients, and gauges the uridine diphosphate glucuronosyl transferase (UGT1A1) polymorphism influence in toxicity and antitumor activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925828.RADuFU5LtWwiwsnxXZniUP5TsVnxY8Jb3uvRLgqLby6-U130_provenance.
- NP946910.RAljbdC4Zi_Bqs-O_vQaQp4G4PqvPdhISLMfeq38DDo8w130_assertion description "[This phase II study assesses the impact of second-line weekly irinotecan (CPT-11)/docetaxel in non-small cell lung cancer (NSCLC) patients, and gauges the uridine diphosphate glucuronosyl transferase (UGT1A1) polymorphism influence in toxicity and antitumor activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946910.RAljbdC4Zi_Bqs-O_vQaQp4G4PqvPdhISLMfeq38DDo8w130_provenance.
- NP418728.RAP67YWI4kbZeBH75HR9wJqrrZsNHTdl4ybVkLBAWuHhw130_assertion description "[This phase II study assesses the impact of second-line weekly irinotecan (CPT-11)/docetaxel in non-small cell lung cancer (NSCLC) patients, and gauges the uridine diphosphate glucuronosyl transferase (UGT1A1) polymorphism influence in toxicity and antitumor activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418728.RAP67YWI4kbZeBH75HR9wJqrrZsNHTdl4ybVkLBAWuHhw130_provenance.